Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)

CUSIP: 04746L104

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock, $0.0001 Par Value
Shares outstanding
9,614,000
Total 13F shares
24,890,216
Share change
+175,745
Total reported value
$233,607,844
Put/Call ratio
172%
Price per share
$9.38
Number of holders
91
Value change
+$136,180
Number of buys
46
Number of sells
37

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 04746L104?
CUSIP 04746L104 identifies ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PERCEPTIVE ADVISORS LLC
13F
Company
36%
3,425,916
$35,081,000 30 Jun 2021
13F
FRANKLIN RESOURCES INC
13F
Company
22%
2,080,050
$21,300,000 30 Jun 2021
13F
BlackRock Finance, Inc.
13F
Company
21%
1,993,048
$20,409,000 30 Jun 2021
13F
RTW INVESTMENTS, LP
13F
Company
20%
1,906,557
$19,523,000 30 Jun 2021
13F
VR Adviser, LLC
13F
Company
15%
1,485,005
$15,206,000 30 Jun 2021
13F
Logos Global Management LP
13F
Company
15%
1,410,812
$14,447,000 30 Jun 2021
13F
VANGUARD GROUP INC
13F
Company
14%
1,367,599
$14,004,000 30 Jun 2021
13F
WASATCH ADVISORS LP
13F
Company
13%
1,222,784
$12,521,000 30 Jun 2021
13F
CITADEL ADVISORS LLC
13F
Company
12%
1,196,706
$12,254,000 30 Jun 2021
13F
BAKER BROS. ADVISORS LP
13F
Company
8.4%
806,367
$8,257,000 30 Jun 2021
13F
Bristlecone Advisors, LLC
13F
Company
7.9%
761,563
$7,798,000 30 Jun 2021
13F
Rock Springs Capital Management LP
13F
Company
7.8%
748,202
$7,662,000 30 Jun 2021
13F
PFM Health Sciences, LP
13F
Company
7.1%
678,247
$6,945,000 30 Jun 2021
13F
PATHSTONE FAMILY OFFICE, LLC
13F
Company
6.9%
661,612
$6,775,000 30 Jun 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
4.6%
445,655
$4,564,000 30 Jun 2021
13F
STATE STREET CORP
13F
Company
4.5%
433,318
$4,437,000 30 Jun 2021
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
4.4%
427,060
$4,373,000 30 Jun 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
4.3%
410,290
$4,201,000 30 Jun 2021
13F
MORGAN STANLEY
13F
Company
2.9%
276,538
$2,831,000 30 Jun 2021
13F
Point72 Asset Management, L.P.
13F
Company
2.1%
199,000
$2,038,000 30 Jun 2021
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
1.7%
163,965
$1,679,000 30 Jun 2021
13F
DAFNA Capital Management LLC
13F
Company
1.7%
160,983
$1,648,000 30 Jun 2021
13F
ROYAL BANK OF CANADA
13F
Company
1.6%
154,730
$1,585,000 30 Jun 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
1.6%
151,986
$1,557,000 30 Jun 2021
13F
Hudson Bay Capital Management LP
13F
Company
1.6%
150,000
$1,536,000 30 Jun 2021
13F
OSAIC HOLDINGS, INC.
13F
Company
1.4%
130,994
$1,341,000 30 Jun 2021
13F
Pentwater Capital Management LP
13F
Company
1.2%
120,000
$1,229,000 30 Jun 2021
13F
KAYNE ANDERSON CAPITAL ADVISORS LP
13F
Company
1.2%
119,930
$1,228,000 30 Jun 2021
13F
SILVERARC CAPITAL MANAGEMENT, LLC
13F
Company
1.2%
117,980
$1,208,000 30 Jun 2021
13F
Nuveen Asset Management, LLC
13F
Company
1.2%
114,135
$1,169,000 30 Jun 2021
13F
NORTHERN TRUST CORP
13F
Company
1%
100,785
$1,032,000 30 Jun 2021
13F
Bank of New York Mellon Corp
13F
Company
0.87%
83,270
$853,000 30 Jun 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.82%
78,800
$807,000 30 Jun 2021
13F
CITIGROUP INC
13F
Company
0.68%
65,763
$673,000 30 Jun 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.61%
58,574
$600,000 30 Jun 2021
13F
Maven Securities LTD
13F
Company
0.59%
56,272
$585,000 30 Jun 2021
13F
Parian Global Management LP
13F
Company
0.57%
55,000
$563,000 30 Jun 2021
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.57%
54,800
$561,000 30 Jun 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.54%
51,843
$531,000 30 Jun 2021
13F
IEQ CAPITAL, LLC
13F
Company
0.52%
49,922
$511,000 30 Jun 2021
13F
Walleye Capital LLC
13F
Company
0.48%
46,421
$475,000 30 Jun 2021
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.46%
44,492
$456,000 30 Jun 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.42%
40,260
$412,000 30 Jun 2021
13F
Lindbrook Capital, LLC
13F
Company
0.42%
40,139
$411,000 30 Jun 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.37%
35,500
$364,000 30 Jun 2021
13F
Clarius Group, LLC
13F
Company
0.34%
32,825
$336,000 30 Jun 2021
13F
Virtu Financial LLC
13F
Company
0.34%
32,662
$334,000 30 Jun 2021
13F
SNOW CAPITAL MANAGEMENT LP
13F
Company
0.31%
30,000
$307,000 30 Jun 2021
13F
SIMPLEX TRADING, LLC
13F
Company
0.3%
29,174
$298,000 30 Jun 2021
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.29%
27,714
$284,000 30 Jun 2021
13F

Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q3 2021

As of 30 Sep 2021, Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by 91 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,890,216 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, FRANKLIN RESOURCES INC, BlackRock Inc., RTW INVESTMENTS, LP, Logos Global Management LP, VANGUARD GROUP INC, VR Adviser, LLC, PATHSTONE FAMILY OFFICE, LLC, CITADEL ADVISORS LLC, and WASATCH ADVISORS INC. This page lists 91 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
86
Q3 2021 holders
91
Holder diff
5
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 Value $ Q3 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.